Joshua Baker will join Ingenium Research, a Cary, NC-based contract research organization, as president and CEO, the company said last week. Baker most recently served as president and CEO of PPGx, a pharmacogenomics research and development company. Previously, he was executive vice president of global operations for PPD Development. Baker holds a PhD and a master’s in statistics from Texas A&M University and a bachelor’s degree in mathematical science from the Pennsylvania State University.
Gerald Fink joined the scientific advisory board of Dyadic International of Jupiter, Fla., the company said last week. Fink is a professor of genetics at the Whitehead Institute/Massachusetts Institute of Technology.
Benitec has appointed to its scientific advisory board Mark Kay, director of the Human Gene Therapy program at Stanford University’s School of Medicine and a professor in pediatrics and genetics. The appointment follows Benitec’s acquisition of Sunnyvale, Calif.-based Avocel, which Kay cofounded. Benitec is based in Queensland, Australia. Kay also sits on the SAB of CombiMatrix.
Additionally, Sara Cunningham, also an Avocel co-founder and the company’s vice president of intellectual property and development, joins Benitec as chief operating officer. Previously, she had worked as a manager at BD Biosciences and Clontech.